Friday 4th June 2004 |
Text too small? |
Latest sales figures showed the tills were ringing a little weakly back home, where sales rose 1.5% for the nine months to March. But the 93 Australian stores turned in sales of $124 million, up 20.7% and the Canadian operations increased sales substantially to $4 million.
As the interim results proved, group return on shareholders' funds of 22.7% and a healthy equity ratio of 45.2% show patient expansion doesn't have to come at a financial cost.
Ironically, the cost of expansion comes in the form of 28 redundancies as the company moves its head office to Brisbane.
The diamond ring manufacturing operation will remain in Whangarei, however, and there are no immediate plans to downsize further.
And as Hill and family still have their feet on a controlling shareholding Michael Hill International isn't likely to join the ranks of successful New Zealand companies snapped up by multinationals any time soon.
The transtasman leap, which was flagged for some time, is not expected to affect the group's profit for the current and next financial year.
The company has plans to operate over 200 stores in Australia and New Zealand and another two sites are under investigation for Canada at this stage.
No comments yet
NZK FY25 Results Announcement details
PEB - Cxbladder Incorporated into AUA Clinical Guideline
SUM - Financial Results for the Year Ended 31 December 2024
SUM - Sustainability Review & Climate-Related Disclosures FY24
MOVE Appoints Paul Millward as CEO
Port of Tauranga reports FY25 interim results
ENS - Half Year Report to 31 December 2024
TruScreen Signs MOU with Hangzhou Dalton Bioscience
February 27th Morning Report
GTK - ASM Chair's address and Presentation